Watertown, MA, United States of America

Douglas Orsi

This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Bayer Aktiengesellschaft, Dana-Farber-Cancer Institute Inc., The Broad Institute, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas Orsi. Retrieved from https://idiyas.com/inventor/douglas-orsi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Douglas Orsi: Innovator in Pharmaceutical Research

Introduction

Douglas Orsi is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of therapeutic compounds. Although he currently holds no granted patents, his work continues to influence the industry.

Latest Patent Applications

Douglas Orsi's latest patent applications include innovative compounds and methods aimed at treating various disorders. One notable application is for Covalent PPARG inverse-agonists, which includes compounds of formula (I) and methods for their preparation and treatment of disorders associated with activated peroxisome proliferator-activated receptor gamma (PPARG), particularly cancer. Another application focuses on Substituted Heterocyclic Compounds and Therapeutic Uses Thereof, detailing compounds of formula (I), processes for their production, and their use as pharmaceuticals.

Conclusion

Douglas Orsi's work in pharmaceutical research showcases his dedication to innovation and the development of new therapeutic solutions. His contributions, although not yet reflected in granted patents, hold promise for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…